SomnoMed Limited Welcomes New Director

Somnomed Limited (AU:SOM) has released an update.

SomnoMed Limited has announced the appointment of Benjamin Gisz as a new director on 8 October 2024, who has a notable interest in 67,716,079 ordinary shares of the company through his relevant interest in TDM Growth Partners Pty Ltd. The declaration made under ASX listing rules marks a significant update to the company’s directorial interests.

For further insights into AU:SOM stock, check out TipRanks’ Stock Analysis page.